Effects of Two Estradiol/Norgestrel Combinations on the Ovulatory Pattern and on Sex Hormone Binding Globulin Capacity in Women Around Forty Years of Age

Abstract. Thirteen women aged 36—46 years (mean 43) who were seeking contraceptive advice, were monitored for 3 months with basal body temperature (BBT) and were then treated for 3 months with CyclabilR (11 tablets of 2 mg es‐tradiol valerate (E2) followed by 10 tablets of 2 mg E2 + 0.5 mg norgestrel). This treatment was immediately followed by another 3 months with CyclabilR + 2 mg E2. BBT revealed a spontaneous ovulatory rate of 89%. Cyclabil reduced the ovulatory rate, as measured with repeated serum progesterone analyses, to 37%, and Cyclabil + 2 mg E2 resulted in a marked reduction in the number of ovulations (3 %). Both types of hormonal combination resulted in relatively small changes in Sex Hormone Binding Globulin Capacity. It is concluded that the addition of 2 mg E2 to CyclabilR causes a decrease in ovulation rate to such an extent that women using this combination run a relatively small risk of conceiving. One advantage over contraceptive steroids may be that the present combination contains a natural estrogen at a relatively low concentration.

[1]  G. Samsioe,et al.  Lipid Metabolic Effects Induced by Two Estradiol/Norgestrel Combinations in Women Around Forty , 1982, Acta obstetricia et gynecologica Scandinavica. Supplement.

[2]  B. V. VON Schoultz,et al.  Effects of sex hormone binding globulin capacity and pregnancy zone protein of treatment with combinations of ethinyl-oestradiol and norethisterone. , 1981, Maturitas.

[3]  V. Wynn,et al.  SEX HORMONE BINDING GLOBULIN CAPACITY AS AN INDEX OF OESTROGENICITY OR ANDROGENICITY IN WOMEN ON ORAL CONTRACEPTIVE STEROIDS , 1979, Clinical endocrinology.

[4]  M. Metcalf Incidence of ovulatory cycles in women approaching the menopause , 1979, Journal of Biosocial Science.

[5]  P. Janson,et al.  The effects of LH, adrenaline and noradrenaline on testicular blood flow and plasma testosterone concentrations in anaesthetized rats. , 1978, Acta endocrinologica.

[6]  E. Johansson,et al.  Effects of d-norgestrel induced decreases in sex hormone binding globulin capacity on the d-norgestrel levels in plasma , 1977 .

[7]  J. Spona,et al.  EXPERIMENTAL AND CLINICAL DATA ON CYCLABIL® * , 1977, Acta obstetricia et gynecologica Scandinavica. Supplement.

[8]  E. Johansson,et al.  Sex hormone binding globulin: the carrier protein for d-norgestrel. , 1976, The Journal of clinical endocrinology and metabolism.

[9]  L. Hamberger,et al.  Influence of Copper Intrauterine Contraceptive Devices (Cu‐7‐Iud) on the Menstrual Blood‐Loss , 1975, Acta obstetricia et gynecologica Scandinavica.

[10]  G. Maroulis,et al.  Evaluation of Ovulation and Corpus Luteum Function Using Measurements of Plasma Progesterone , 1974, Obstetrics and gynecology.

[11]  David C. Anderson,et al.  SEX‐HORMONE‐BINDING GLOBULIN , 1974, Clinical endocrinology.

[12]  P. Albertsson,et al.  A new method for the determination of the binding capacity of testosterone-estradiol-binding-globulin in human plasma. , 1973, Journal of steroid biochemistry.

[13]  F. Rodkey DIRECT SPECTROPHOTOMETRIC DETERMINATION OF ALBUMIN IN HUMAN SERUM. , 1965, Clinical chemistry.

[14]  G. Silfverstolpe,et al.  Oral contraception with a nonalkylated estrogen component. Effects on lipid metabolism. , 1983, Gynecologic and obstetric investigation.

[15]  D. Mishell,et al.  Changes in physiologically free circulating estradiol and testosterone during exposure to levonorgestrel. , 1981, The Journal of clinical endocrinology and metabolism.

[16]  A. Svanborg,et al.  Lipid metabolic studies in oophorectomized women: effects induced by two different estrogens on serum lipids and lipoproteins. , 1980, Gynecologic and obstetric investigation.

[17]  F. Naftolin,et al.  The hypothalamus and control of ovulation. , 1970, British medical bulletin.

[18]  Wynn,et al.  Effects on lipid metabolism. , 1969 .

[19]  G. Richardson Ovarian physiology. , 1966, The New England journal of medicine.